Evidence map›Paper›PMID 36235126›Full record

ArticleMolecules (Basel, Switzerland)2022

In Vitro and In Vivo Characterization of

Kevin J H Allen, Rubin Jiao, Jason Li, Denis R Beckford-Vera, Ekaterina Dadachova

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. European journal of nuclear medicine and molecular imaging · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Kevin J H AllenCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Rubin JiaoCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Jason LiActinium Pharmaceuticals, New York, NY 10016, USA.
Denis R Beckford-VeraActinium Pharmaceuticals, New York, NY 10016, USA.
Ekaterina DadachovaCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
University of Saskatchewan · CAActinium Pharmaceuticals (United States) · US

Funding

Actinium Pharmaceuticals (United States) 419625
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DeferoxamineZirconiumAnimalsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedCell Line, TumorHumansMiceMice, SCIDPositron-Emission TomographyPositron Emission Tomography Computed TomographyTissue DistributionAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedDeferoxaminelintuzumabZirconium89Zirconiumacute myeloid leukemialintuzumabpositron emission tomography

Identifiers

PMID36235126
PMCPMC9571394
OpenAlexW4303959084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.